Ontology highlight
ABSTRACT: Background
Soluble oligomeric (misfolded) species of amyloid-β (Aβ) are the main mediators of toxicity in Alzheimer's disease (AD). These oligomers subsequently form aggregates of insoluble fibrils that precipitate as extracellular and perivascular plaques in the brain. Active immunization against Aβ is a promising disease modifying strategy. However, eliciting an immune response against Aβ in general may interfere with its biological function and was shown to cause unwanted side-effects. Therefore, we have developed a novel experimental vaccine based on conformational neo-epitopes that are exposed in the misfolded oligomeric Aβ, inducing a specific antibody response.Objective
Here we investigate the protective effects of the experimental vaccine against oligomeric Aβ1-42-i
SUBMITTER: Mulder CK
PROVIDER: S-EPMC4927839 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature